WILLIAM BAREFOOT: Open Payments
NPI 1548286149 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 31 payments from 7 companies in 2025. Trend: 2023 $214 · 2024 $409 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 21 | $414 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Liquidia Technologies, Inc. | 2 | $36 |
| Viatris Specialty LLC | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| United Therapeutics Corporation | 1 | $19 |
Products named: NUCALA, TRELEGY ELLIPTA, DUPIXENT, YUTREPIA, YUPELRI, ACTHAR, Tyvaso.
Industry payments across PA — which companies pay providers there.
